Tevis Investment Management Purchases 166 Shares of CME Group Inc. $CME

Tevis Investment Management lifted its position in CME Group Inc. (NASDAQ:CME) by 8.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,120 shares of the financial services provider’s stock after acquiring an additional 166 shares during the period. Tevis Investment Management’s holdings in CME Group were worth $584,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Catalyst Capital Advisors LLC raised its position in shares of CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after acquiring an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. bought a new position in shares of CME Group in the 1st quarter worth approximately $367,000. Fulcrum Equity Management bought a new position in shares of CME Group in the 1st quarter worth approximately $258,000. AIA Group Ltd raised its position in shares of CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares in the last quarter. Finally, Insight Inv LLC bought a new position in shares of CME Group in the 1st quarter worth approximately $2,712,000. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Barclays reduced their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Keefe, Bruyette & Woods raised their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research report on Monday, October 13th. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Finally, Raymond James Financial reduced their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $284.53.

Insiders Place Their Bets

In other news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Up 0.6%

CME Group stock opened at $271.09 on Tuesday. The firm has a market cap of $97.70 billion, a price-to-earnings ratio of 26.27, a PEG ratio of 6.65 and a beta of 0.41. The stock has a fifty day simple moving average of $266.48 and a two-hundred day simple moving average of $272.02. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.68 EPS. Equities analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.